Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Does drinking a small amount of anti-foam before endoscopy improve the views obtained?
ISRCTN ISRCTN30607490
ClinicalTrials.gov identifier
Public title Does drinking a small amount of anti-foam before endoscopy improve the views obtained?
Scientific title
Acronym N/A
Serial number at source N0436118041
Study hypothesis We will undertake a prospective, double-dummy controlled study to determine:
1. Are the endoscopic views improved significantly with the use of anti-foam pre-medication?
2. Can the endoscopic examination be carried out quicker with the use antifoam pre-medication?
3. Are we able to detect more significant abnormalities with the use of antifoam pre-medication?
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Surgery: Anaesthesia
Participants - inclusion criteria All patients able to give informed consent and referred for upper digestive endoscopy at lower gastrointestinal (LGI).
Participants - exclusion criteria Ventilated patients, patients with dysphagia or unable to swallow a mouthful of liquid for any reason, patients already included in a separate endoscopy study will not be recruited.
Anticipated start date 30/06/2002
Anticipated end date 30/12/2005
Status of trial Completed
Patient information material
Target number of participants 200
Interventions Anti-foam before endoscopy vs standard practice.
Primary outcome measure(s) Improved endoscopic views of gastric mucosa. Patient opinion on the pre-medication drink, duration of the endoscopy as measured from intubation to extubation, the endoscopists views of the areas of the upper digestive tract will be assessed, rating of the amount of mucosa seen without having to resort to washing the area, independent rating of the proportion of mucosa obscured by bubbles or mucus, endoscopic findings.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Leeds Teaching Hospitals NHS Trust (UK) NHS R&D Support Funding
Trial website
Publications
Contact name Dr  B J  Rembacken
  Address Gastroenterology
Clarendon Wing
Leeds General Infirmary
  City/town Leeds
  Zip/Postcode LS1 3EX
  Country United Kingdom
  Tel +44 (0)113 243 2799
  Fax +44 (0)113 392 6336
  Email
Sponsor Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2005
Last edited 25/02/2010
Date ISRCTN assigned 30/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central